MARKET

RPRX

RPRX

Royalty Pharma Plc
NASDAQ
38.96
+0.06
+0.15%
After Hours: 39.10 +0.14 +0.36% 18:39 02/03 EST
OPEN
38.86
PREV CLOSE
38.90
HIGH
39.14
LOW
38.68
VOLUME
1.36M
TURNOVER
0
52 WEEK HIGH
44.75
52 WEEK LOW
35.67
MARKET CAP
23.66B
P/E (TTM)
33.59
1D
5D
1M
3M
1Y
5Y
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
Benzinga · 3d ago
Royalty Pharma: Uncorrelated Yield From Pharmaceutical Product In Uncertain Times
Seeking Alpha · 4d ago
Tracking Baillie Gifford's 13F Portfolio - Q4 2022 Update
Seeking Alpha · 4d ago
Global drug spending to reach $1.9T by 2027 – IQVIA
Seeking Alpha · 01/22 17:00
Ominous Death Cross Forms On Royalty Pharma's Chart
Benzinga · 01/10 14:48
Royalty Pharma: An Attractive Business Model But An Uncertain Outcome For Vertex's CF Royalties
Seeking Alpha · 01/10 04:13
Ionis, Royalty Pharma ink royalty deal for up to $1.1B
Seeking Alpha · 01/09 14:44
Royalty Pharma Highlights Accomplishments And Provides Business Update; 2022 Net Cash Provided By Operating Activities Expected To Be ~$2.14B-$2.15B; 2022 Adjusted Cash Receipts Expected To Be ~$2.785B-$2.790B, Towards The Upper End Of Guidance Range
Benzinga · 01/09 14:32
More
About RPRX
Royalty Pharma plc is engaged in investing in late stage biopharmaceutical products. The Company invests in academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. The Company’s portfolio of pharmaceutical investment includes investments in commercial products and development-stage product candidates. Its portfolio investments include AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko, Trikafta and OXLUMO.

Webull offers kinds of Royalty Pharma plc stock information, including NASDAQ:RPRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RPRX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RPRX stock methods without spending real money on the virtual paper trading platform.